お知らせ • Oct 08
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders Greater Cannabis Company, Inc. announced that it has submitted a clinical trial application to the Israel Ministry of Health for approval of a Phase 2 clinical trial for its novel neuropsychiatric cannabinoid therapy. The Company intends to conduct a Phase 2 clinical trial spearheaded by principal investigator, Dr. Adi Aran, to study the safety and efficacy of its neuroprotective cannabinoid therapeutic to treat autism related spectrum disorders (ASD) and other neuropsychiatric illnesses. The study will be conducted as a double-blind, placebo controlled trial with 100 patients ranging in age from 4-17 years old. The study is expected to begin enrolling patients in the first half of 2023, pending approval of the Health Ministry, and to run for 12 to 18 months, including a possible open-label phase. The Company looks forward to updating shareholders on the approval of the Phase 2 study as it progresses through the review process. お知らせ • Apr 03
The Greater Cannabis Company, Inc. announced delayed annual 10-K filing On 04/01/2022, The Greater Cannabis Company, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. お知らせ • Aug 18
The Greater Cannabis Company, Inc. announced delayed 10-Q filing On 08/17/2021, The Greater Cannabis Company, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Nov 25
The Greater Cannabis Company Announces Launch of Bob Ross Beauty and Cosmetics Products The Greater Cannabis Company, Inc. to update shareholders on its recent launch of a line of beauty and cosmetics products under the Bob Ross license. The Company, through its Koltuv Ventures partnership, is developing and commercializing products under the highly sought out Bob Ross licensing program for use in beauty and cosmetics categories. The first cosmetic items in the Bob Ross Beauty line will include a collection of lip tints and eyeshadows that are based on actual colors created by Bob Ross, which he used to create some of his iconic works. Starting with his beloved PBS series, "The Joy of Painting," Bob Ross became a cultural icon celebrated by generations of fans. His calm demeanor and supportive tone brought the literal joy of painting to enthusiasts around the world. Recently this iconic brand has been reinvigorated by a new generation of consumers looking for authentic and uplifting positivity and calmness. Now with a strong nostalgia for the show and new fans by way of streaming, Bob Ross went from this unassuming creative artist to now this pop culture icon. お知らせ • Nov 18
The Greater Cannabis Company, Inc. announced delayed 10-Q filing On 11/16/2020, The Greater Cannabis Company, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Aug 14
The Greater Cannabis Company, Inc. announced delayed 10-Q filing On 08/13/2020, The Greater Cannabis Company, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.